V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20018870 | 20085478 | 1.44 | 90.3 | Palliative (P) | 2018-09-21 | 2018-09-22 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100929782 |
| 20018874 | 20085479 | 1.75 | 69 | Palliative (P) | 2018-08-01 | 2018-08-02 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100439415 |
| 20018895 | 20085480 | 1.71 | 105.2 | Palliative (P) | 2019-01-14 | 2019-05-02 | Cisplatin | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101229326 |
| 20018951 | 20085481 | 0.36 | 80.8 | Palliative (P) | 2018-11-22 | 2018-12-01 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101044645 |
| 20019272 | 20085485 | 1.8 | 117.6 | Palliative (P) | 2020-05-08 | 2020-05-09 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101391520 |
| 20019395 | 20085487 | 1.67 | 79 | Palliative (P) | 2019-05-26 | 2019-05-29 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100528442 |
| 20019438 | 20085488 | 0 | null | null | 2019-05-17 | 2019-06-08 | Enzalutamide | 02 | null | CARBOPLATIN | 101047610 |
| 20019454 | 20085489 | 1.73 | 89 | null | 2018-11-10 | 2018-12-07 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 101518352 |
| 20019648 | 20085490 | 1.8 | 69 | Palliative (P) | 2021-10-23 | 2021-11-08 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100257431 |
| 20019657 | 20085492 | 1.57 | 66.2 | null | 2020-03-15 | 2020-03-22 | CARBOPLATIN + PACLITAXEL + RT | N | null | CARBOPLATIN + PACLITAXEL + RT | 100781890 |
| 20019667 | 20085493 | 1.8 | 87.1 | Palliative (P) | 2017-08-21 | 2017-09-09 | Oxaliplatin + Raltitrexed | N | Y | OXALIPLATIN + RALTITREXED | 100478985 |
| 20019773 | 20085494 | 1.8 | 72.25 | Adjuvant (A) | 2020-06-01 | 2020-06-02 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101262824 |
| 20019832 | 20085495 | 1.75 | 72.8 | Palliative (P) | 2019-11-16 | 2019-11-18 | Enzalutamide | null | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101499460 |
| 20019917 | 20085496 | 1.5 | 90.3 | null | 2019-11-27 | 2019-11-27 | Enzalutamide | N | Y | CISPLATIN | 100477471 |
| 20019956 | 20085497 | 1.5 | 68.7 | Neo-adjuvant (N) | 2020-07-05 | 2020-07-26 | LU-177 | 02 | null | LUTETIUM-177 | 101260775 |
| 20020002 | 20085498 | 1.81 | 124 | Curative (C) | 2019-01-19 | 2019-02-06 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100609676 |
| 20020011 | 20085499 | 1.56 | 81.2 | Curative (C) | 2017-03-25 | 2017-03-26 | Enzalutamide | 02 | Y | CARBOPLATIN | 100708898 |
| 20020119 | 20085500 | null | null | Curative (C) | 2017-03-30 | 2017-04-08 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100412374 |
| 20020361 | 20085501 | 1.74 | 79.7 | null | 2017-02-22 | 2017-03-09 | Enzalutamide | 02 | null | OCTREOTIDE | 100484997 |
| 20020739 | 20085502 | 1.81 | 65.2 | null | 2018-11-30 | 2018-12-16 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101012696 |
| 20020860 | 20085503 | 1.83 | 100 | Curative (C) | 2019-06-22 | 2019-06-22 | Enzalutamide | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 101142967 |
| 20020881 | 20085504 | 1.75 | 103.2 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-12 | Enzalutamide | 02 | N | ECF | 101126477 |
| 20021132 | 20085505 | 1.64 | 79.3 | Curative (C) | 2017-04-24 | 2017-04-29 | Enzalutamide | 02 | N | ECF | 100754243 |
| 20021243 | 20085506 | 1.5 | 79 | Palliative (P) | 2018-01-20 | 2018-01-25 | Enzalutamide | 02 | N | CETUXIMAB | 100261071 |
| 20021513 | 20085509 | 1.91 | 98 | Curative (C) | 2019-10-02 | 2019-10-16 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | CARBOPLATIN + PACLITAXEL + RT | 101838494 |
| 20021552 | 20085510 | 1.76 | 96.7 | Palliative (P) | 2020-11-07 | 2020-11-14 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN + RT | 100988416 |
| 20021820 | 20085512 | 1.85 | 83.2 | Curative (C) | 2019-11-05 | 2019-11-08 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100176064 |
| 20021931 | 20085513 | 0 | 0 | Curative (C) | 2020-07-17 | 2020-07-23 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + GEMCITABINE | 100118036 |
| 20021938 | 20085514 | 1.72 | 59.7 | Neo-adjuvant (N) | 2019-10-30 | 2019-11-09 | Panitumumab + Irinotecan + MdG | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101015040 |
| 20021962 | 20085515 | 1.65 | 138.55 | Adjuvant (A) | null | 2018-11-11 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101330724 |
| 20022013 | 20085516 | 1.7 | 85.5 | Curative (C) | 2018-10-31 | 2018-10-31 | Enzalutamide | null | N | ATEZOLIZUMAB + BEVACIZUMAB | 100557664 |
| 20022051 | 20085517 | 0 | 67 | Curative (C) | 2017-04-17 | 2017-04-17 | ECF | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101270074 |
| 20022089 | 20085518 | 1.67 | 93.3 | Neo-adjuvant (N) | 2019-11-18 | 2019-11-27 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101399611 |
| 20022145 | 20085519 | 1.57 | 81.9 | null | 2020-03-22 | 2020-03-27 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 101355962 |
| 20022150 | 20085520 | 1.75 | 59 | Neo-adjuvant (N) | 2021-04-10 | 2021-04-15 | Enzalutamide | 02 | Y | SCALOP-2 TRIAL | 100800895 |
| 20022266 | 20085521 | 1.83 | 85.2 | null | 2017-12-19 | 2017-12-23 | Enzalutamide | null | null | CETUXIMAB + OXALIPLATIN + MDG | 100163290 |
| 20022300 | 20085522 | null | 85.1 | Palliative (P) | 2022-02-06 | 2022-02-14 | Enzalutamide | 02 | Y | OCTREOTIDE | 100661659 |
| 20022408 | 20085523 | 1.74 | null | Palliative (P) | 2019-12-05 | 2019-12-17 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 101580550 |
| 20022481 | 20085525 | 1.67 | 107.1 | Palliative (P) | 2018-12-24 | 2019-01-17 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101089595 |
| 20022518 | 20085526 | 1.77 | 62.4 | null | 2021-01-30 | 2021-01-30 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101001780 |
| 20022542 | 20085527 | 1.82 | 66.9 | Neo-adjuvant (N) | 2016-11-02 | 2016-11-14 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100552465 |
| 20022593 | 20085528 | 1.75 | 77.3 | Palliative (P) | 2020-01-16 | 2020-01-16 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100445932 |
| 20022716 | 20085530 | 1.49 | 59 | null | 2019-04-17 | 2019-04-17 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 101196734 |
| 20022725 | 20085531 | null | null | Neo-adjuvant (N) | 2020-07-11 | 2020-07-23 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100299675 |
| 20022727 | 20085532 | 1.67 | 48.6 | Neo-adjuvant (N) | 2017-08-05 | 2017-08-06 | Enzalutamide | 02 | N | OCTREOTIDE | 100968305 |
| 20022800 | 20085534 | 0 | 0 | Palliative (P) | 2021-05-04 | 2021-05-04 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100326545 |
| 20022813 | 20085535 | 1.82 | null | Neo-adjuvant (N) | 2021-11-06 | 2021-11-18 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 101450961 |
| 20022964 | 20085536 | 0 | 0 | Palliative (P) | 2020-09-29 | 2020-10-06 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | CISPLATIN | 100317686 |
| 20023209 | 20085538 | 1.7 | 84 | Palliative (P) | 2018-05-12 | 2018-05-20 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101195989 |
| 20023214 | 20085539 | 1.75 | null | Curative (C) | 2018-11-30 | 2018-12-11 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101267881 |